CMXHF
CSL Limited
Price Chart
Latest Quote
$135.00
+0.00 (+0.00%)
Current Price
| Previous Close | $135.00 |
| Open | $135.00 |
| Day High | $135.00 |
| Day Low | $135.00 |
| Volume | 500 |
Stock Information
| Quarterly Dividend / Yield | $2.83 / 2.10% |
| Shares Outstanding | 479.88M |
| Quarterly Dividend Yield | 2.10% |
| Quarterly Dividend | $2.83 |
| Total Debt | $10.90B |
| Cash Equivalents | $1.51B |
| Revenue | $15.80B |
| Net Income | $-2.58B |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $64.78B |
| EPS (TTM) | $-5.35 |
| Exchange | OQX |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $75.55B |
| Sales | $15.80B |
| Income | $-2.58B |
| Book/sh | $30.90 |
| Cash/sh | $3.15 |
| Employees | 29K |
Financial Ratios
| Quick Ratio | 0.91 |
| Current Ratio | 2.21 |
| Debt/Eq | 66.82 |
Returns & Margins
| ROA | 7.26% |
| ROE | -15.83% |
| Gross Margin | 51.12% |
| Operating Margin | 21.49% |
| Profit Margin | -16.33% |
Ownership
| Insider Ownership | 0.02% |
| Institutional Ownership | 38.31% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 4.10 |
| P/B | 4.37 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $129.13 |
| SMA50 | $125.41 |
| SMA200 | $100.00 |
| RSI | 89.27 |
| ATR | 1.6529 |
| Shares Float | 478.53M |
| Volatility | 0.08 |
Performance History
| Week | -1.39% |
| Month | +5.88% |
| Quarter | +55.65% |
| 6 Months | +57.48% |
| YTD | +15.94% |
| Year | +23.72% |
| 3 Years | -5.24% |
| 5 Years | -35.34% |
| 10 Years | +104.45% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-29 | $135.00 | 0 |
| 2026-10-28 | $135.00 | 0 |
| 2026-10-27 | $135.00 | 1,100 |
| 2026-10-26 | $136.90 | 0 |
| 2026-10-23 | $136.90 | 0 |
| 2026-10-22 | $136.90 | 0 |
| 2026-10-21 | $136.90 | 2,600 |
| 2026-10-20 | $135.96 | 200 |
| 2026-10-19 | $127.08 | 900 |
| 2026-10-16 | $123.79 | 0 |
| 2026-10-15 | $123.79 | 600 |
| 2026-10-14 | $121.10 | 0 |
| 2026-10-13 | $121.10 | 0 |
| 2026-10-12 | $121.10 | 0 |
| 2026-10-09 | $121.10 | 500 |
| 2026-10-08 | $126.03 | 0 |
| 2026-10-07 | $126.03 | 900 |
| 2026-10-06 | $127.68 | 0 |
| 2026-10-05 | $127.68 | 100 |
| 2026-10-02 | $127.50 | 0 |
| 2026-10-01 | $127.50 | 0 |
| 2026-09-30 | $127.50 | 100 |
About CSL Limited
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. The company's therapeutic areas includes Immunoglobulins, Immunology, Immunology Haematology, Cardiovascular and Renal, and Vaccines. It also licenses CSL intellectual property. It also develops vaccines for the prevention of infectious disease. The company has strategic collaboration with Dutch biotech company VarmX BV for the development of VMX-C001 to help restore blood coagulation in patients requiring urgent surgery; and Alentis Therapeutics AG to develop and commercialise lixudebart for rare kidney and liver diseases. The company was formerly known as Commonwealth Serum Laboratories Limited and later changed its name to CSL Limited in October 1991. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
đ° Latest News
No news articles available at the moment. Check back later for updates on CMXHF.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $7,479,000,000 | $7,129,000,000 | $6,466,000,000 | $4,829,600,000 |
| Cost Of Revenue | $7,479,000,000 | $7,129,000,000 | $6,466,000,000 | $4,829,600,000 |
| Total Revenue | $15,430,000,000 | $14,690,000,000 | $13,174,000,000 | $10,493,100,000 |
| Operating Revenue | $15,430,000,000 | $14,690,000,000 | $13,174,000,000 | $10,493,100,000 |
| Expenses | ||||
| Interest Expense | $393,000,000 | $420,000,000 | $408,000,000 | $142,800,000 |
| Other Income Expense | $158,000,000 | $110,000,000 | $136,000,000 | $81,600,000 |
| Other Non Operating Income Expenses | $158,000,000 | $110,000,000 | $136,000,000 | $81,600,000 |
| Net Non Operating Interest Income Expense | $-410,000,000 | $-437,000,000 | $-406,000,000 | $-160,600,000 |
| Total Other Finance Cost | $55,000,000 | $56,000,000 | $36,000,000 | $35,200,000 |
| Interest Expense Non Operating | $393,000,000 | $420,000,000 | $408,000,000 | $142,800,000 |
| Operating Expense | $4,992,000,000 | $4,797,000,000 | $4,606,000,000 | $3,347,400,000 |
| Selling And Marketing Expense | $1,616,000,000 | $1,573,000,000 | $1,454,000,000 | $960,700,000 |
| General And Administrative Expense | $1,000,000,000 | $856,000,000 | $1,086,000,000 | $688,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $3,002,000,000 | $2,642,000,000 | $2,194,000,000 | $2,254,700,000 |
| Net Interest Income | $-410,000,000 | $-437,000,000 | $-406,000,000 | $-160,600,000 |
| Interest Income | $38,000,000 | $39,000,000 | $38,000,000 | $17,400,000 |
| Normalized Income | $3,002,000,000 | $2,642,000,000 | $2,194,000,000 | $2,254,700,000 |
| Net Income From Continuing And Discontinued Operation | $3,002,000,000 | $2,642,000,000 | $2,194,000,000 | $2,254,700,000 |
| Net Income Common Stockholders | $3,002,000,000 | $2,642,000,000 | $2,194,000,000 | $2,254,700,000 |
| Net Income | $3,002,000,000 | $2,642,000,000 | $2,194,000,000 | $2,254,700,000 |
| Net Income Including Noncontrolling Interests | $3,136,000,000 | $2,714,000,000 | $2,244,000,000 | $2,254,700,000 |
| Net Income Continuous Operations | $3,136,000,000 | $2,714,000,000 | $2,244,000,000 | $2,254,700,000 |
| Pretax Income | $3,724,000,000 | $3,375,000,000 | $2,663,000,000 | $2,779,600,000 |
| Interest Income Non Operating | $38,000,000 | $39,000,000 | $38,000,000 | $17,400,000 |
| Operating Income | $2,959,000,000 | $2,764,000,000 | $2,102,000,000 | $2,316,100,000 |
| Depreciation Amortization Depletion Income Statement | $1,017,000,000 | $938,000,000 | $831,000,000 | $542,500,000 |
| Depreciation And Amortization In Income Statement | $1,017,000,000 | $938,000,000 | $831,000,000 | $542,500,000 |
| Amortization Of Intangibles Income Statement | $468,000,000 | $410,000,000 | $341,000,000 | $96,800,000 |
| Depreciation Income Statement | $549,000,000 | $528,000,000 | $490,000,000 | $445,700,000 |
| Gross Profit | $7,951,000,000 | $7,561,000,000 | $6,708,000,000 | $5,663,500,000 |
| Per Share | ||||
| Diluted EPS | $6.17 | $5.45 | $4.53 | $4.80 |
| Basic EPS | $6.20 | $5.47 | $4.55 | $4.81 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $5,134,000,000 | $4,733,000,000 | $3,902,000,000 | $3,464,900,000 |
| Reconciled Depreciation | $1,017,000,000 | $938,000,000 | $831,000,000 | $542,500,000 |
| EBITDA (Bullshit earnings) | $5,134,000,000 | $4,733,000,000 | $3,902,000,000 | $3,464,900,000 |
| EBIT | $4,117,000,000 | $3,795,000,000 | $3,071,000,000 | $2,922,400,000 |
| Diluted Average Shares | $486,547,812 | $484,770,642 | $484,326,711 | $469,729,167 |
| Basic Average Shares | $484,041,060 | $483,010,851 | $482,173,148 | $468,754,857 |
| Minority Interests | $-134,000,000 | $-72,000,000 | $-50,000,000 | - |
| Tax Provision | $588,000,000 | $661,000,000 | $419,000,000 | $524,900,000 |
| Amortization | $468,000,000 | $410,000,000 | $341,000,000 | $96,800,000 |
| Research And Development | $1,359,000,000 | $1,430,000,000 | $1,235,000,000 | $1,156,200,000 |
| Selling General And Administration | $2,616,000,000 | $2,429,000,000 | $2,540,000,000 | $1,648,700,000 |
| Other Gand A | $1,000,000,000 | $856,000,000 | $1,086,000,000 | $688,000,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,150,000,000 | $1,017,000,000 | $-660,000,000 | $11,939,400,000 |
| Total Assets | $39,404,000,000 | $38,022,000,000 | $36,234,000,000 | $28,346,000,000 |
| Total Non Current Assets | $27,554,000,000 | $27,254,000,000 | $26,975,000,000 | $11,885,300,000 |
| Non Current Deferred Assets | $1,091,000,000 | $911,000,000 | $902,000,000 | $517,500,000 |
| Non Current Deferred Taxes Assets | $1,091,000,000 | $911,000,000 | $902,000,000 | $517,500,000 |
| Non Current Accounts Receivable | $189,000,000 | $158,000,000 | $96,000,000 | $12,800,000 |
| Goodwill And Other Intangible Assets | $16,185,000,000 | $16,346,000,000 | $16,446,000,000 | $2,638,100,000 |
| Other Intangible Assets | $8,120,000,000 | $8,267,000,000 | $8,367,000,000 | $1,450,800,000 |
| Current Assets | $11,850,000,000 | $10,768,000,000 | $9,259,000,000 | $16,460,700,000 |
| Current Deferred Assets | $86,000,000 | $126,000,000 | $31,000,000 | $29,900,000 |
| Current Deferred Taxes Assets | $86,000,000 | $126,000,000 | $31,000,000 | $29,900,000 |
| Prepaid Assets | $259,000,000 | $254,000,000 | $300,000,000 | $174,000,000 |
| Inventory | $6,466,000,000 | $5,964,000,000 | $5,466,000,000 | $4,333,000,000 |
| Receivables | $2,882,000,000 | $2,641,000,000 | $1,905,000,000 | $1,483,200,000 |
| Receivables Adjustments Allowances | $-21,000,000 | $-16,000,000 | $-12,000,000 | $-16,900,000 |
| Other Receivables | $620,000,000 | $571,000,000 | $493,000,000 | $534,300,000 |
| Accounts Receivable | $2,283,000,000 | $2,086,000,000 | $1,424,000,000 | $965,800,000 |
| Cash Cash Equivalents And Short Term Investments | $2,157,000,000 | $1,657,000,000 | $1,548,000,000 | $10,436,400,000 |
| Cash And Cash Equivalents | $2,157,000,000 | $1,657,000,000 | $1,548,000,000 | $10,436,400,000 |
| Cash Equivalents | $963,000,000 | $772,000,000 | $552,000,000 | $8,905,400,000 |
| Cash Financial | $1,194,000,000 | $885,000,000 | $996,000,000 | $1,531,000,000 |
| Assets Held For Sale Current | - | $126,000,000 | - | - |
| Other Current Assets | - | - | $9,000,000 | $4,200,000 |
| Debt | ||||
| Net Debt | $7,679,000,000 | $8,862,000,000 | $8,980,000,000 | - |
| Total Debt | $11,498,000,000 | $12,183,000,000 | $12,227,000,000 | $9,657,800,000 |
| Long Term Debt And Capital Lease Obligation | $10,694,000,000 | $11,239,000,000 | $11,172,000,000 | $5,163,800,000 |
| Long Term Debt | $9,141,000,000 | $9,671,000,000 | $9,564,000,000 | $3,862,500,000 |
| Current Debt And Capital Lease Obligation | $804,000,000 | $944,000,000 | $1,055,000,000 | $4,494,000,000 |
| Current Debt | $695,000,000 | $848,000,000 | $964,000,000 | $4,420,500,000 |
| Other Current Borrowings | $282,000,000 | $585,000,000 | $602,000,000 | $311,300,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $17,997,000,000 | $18,621,000,000 | $18,408,000,000 | $13,768,500,000 |
| Total Non Current Liabilities Net Minority Interest | $13,182,000,000 | $13,671,000,000 | $13,800,000,000 | $6,660,300,000 |
| Other Non Current Liabilities | $227,000,000 | $220,000,000 | $493,000,000 | $535,700,000 |
| Tradeand Other Payables Non Current | $288,000,000 | $230,000,000 | - | - |
| Non Current Deferred Liabilities | $1,510,000,000 | $1,514,000,000 | $1,464,000,000 | $670,100,000 |
| Non Current Deferred Taxes Liabilities | $1,510,000,000 | $1,514,000,000 | $1,464,000,000 | $670,100,000 |
| Current Liabilities | $4,815,000,000 | $4,950,000,000 | $4,608,000,000 | $7,108,200,000 |
| Current Deferred Liabilities | $280,000,000 | $176,000,000 | $296,000,000 | $131,500,000 |
| Current Deferred Taxes Liabilities | $280,000,000 | $176,000,000 | $296,000,000 | $131,500,000 |
| Current Notes Payable | $413,000,000 | $263,000,000 | $362,000,000 | $4,109,200,000 |
| Payables And Accrued Expenses | $3,461,000,000 | $3,345,000,000 | $2,947,000,000 | $2,301,200,000 |
| Payables | $3,461,000,000 | $3,345,000,000 | $2,947,000,000 | $2,301,200,000 |
| Other Payable | $2,653,000,000 | $2,478,000,000 | $2,127,000,000 | $1,709,400,000 |
| Accounts Payable | $808,000,000 | $867,000,000 | $820,000,000 | $591,800,000 |
| Other Current Liabilities | - | $10,000,000 | - | - |
| Equity | ||||
| Common Stock Equity | $19,335,000,000 | $17,363,000,000 | $15,786,000,000 | $14,577,500,000 |
| Total Equity Gross Minority Interest | $21,407,000,000 | $19,401,000,000 | $17,826,000,000 | $14,577,500,000 |
| Stockholders Equity | $19,335,000,000 | $17,363,000,000 | $15,786,000,000 | $14,577,500,000 |
| Gains Losses Not Affecting Retained Earnings | $1,017,000,000 | $794,000,000 | $648,000,000 | $590,300,000 |
| Other Equity Adjustments | $1,062,000,000 | $907,000,000 | $746,000,000 | $670,700,000 |
| Retained Earnings | $17,744,000,000 | $16,012,000,000 | $14,621,000,000 | $13,503,400,000 |
| Other | ||||
| Ordinary Shares Number | $484,212,123 | $483,252,729 | $482,369,261 | $481,706,266 |
| Share Issued | $484,212,123 | $483,252,729 | $482,369,261 | $481,706,266 |
| Tangible Book Value | $3,150,000,000 | $1,017,000,000 | $-660,000,000 | $11,939,400,000 |
| Invested Capital | $29,171,000,000 | $27,882,000,000 | $26,314,000,000 | $22,860,500,000 |
| Working Capital | $7,035,000,000 | $5,818,000,000 | $4,651,000,000 | $9,352,500,000 |
| Capital Lease Obligations | $1,662,000,000 | $1,664,000,000 | $1,699,000,000 | $1,374,800,000 |
| Total Capitalization | $28,476,000,000 | $27,034,000,000 | $25,350,000,000 | $18,440,000,000 |
| Minority Interest | $2,072,000,000 | $2,038,000,000 | $2,040,000,000 | - |
| Foreign Currency Translation Adjustments | $-45,000,000 | $-113,000,000 | $-98,000,000 | $-80,400,000 |
| Capital Stock | $574,000,000 | $557,000,000 | $517,000,000 | $483,800,000 |
| Common Stock | $574,000,000 | $557,000,000 | $517,000,000 | $483,800,000 |
| Employee Benefits | $366,000,000 | $334,000,000 | $264,000,000 | $189,000,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $366,000,000 | $334,000,000 | $264,000,000 | $189,000,000 |
| Long Term Capital Lease Obligation | $1,553,000,000 | $1,568,000,000 | $1,608,000,000 | $1,301,300,000 |
| Long Term Provisions | $97,000,000 | $134,000,000 | $407,000,000 | $101,700,000 |
| Current Capital Lease Obligation | $109,000,000 | $96,000,000 | $91,000,000 | $73,500,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $234,000,000 | $213,000,000 | $246,000,000 | - |
| Current Provisions | $36,000,000 | $262,000,000 | $64,000,000 | $181,500,000 |
| Defined Pension Benefit | $89,000,000 | $18,000,000 | $6,000,000 | $5,400,000 |
| Investments And Advances | $203,000,000 | $163,000,000 | $173,000,000 | $402,900,000 |
| Other Investments | $203,000,000 | $163,000,000 | $173,000,000 | $402,900,000 |
| Goodwill | $8,065,000,000 | $8,079,000,000 | $8,079,000,000 | $1,187,300,000 |
| Net PPE | $9,797,000,000 | $9,658,000,000 | $9,352,000,000 | $8,308,600,000 |
| Accumulated Depreciation | $-4,342,000,000 | $-3,887,000,000 | $-3,468,000,000 | $-3,152,000,000 |
| Gross PPE | $14,139,000,000 | $13,545,000,000 | $12,820,000,000 | $11,460,600,000 |
| Leases | $687,000,000 | $685,000,000 | $666,000,000 | $597,400,000 |
| Construction In Progress | $2,975,000,000 | $2,981,000,000 | $2,771,000,000 | $3,081,600,000 |
| Other Properties | $2,199,000,000 | $2,164,000,000 | $2,134,000,000 | $1,848,800,000 |
| Machinery Furniture Equipment | $5,659,000,000 | $5,274,000,000 | $4,900,000,000 | $4,078,400,000 |
| Land And Improvements | $2,619,000,000 | $2,441,000,000 | $2,349,000,000 | $1,854,400,000 |
| Finished Goods | $2,384,000,000 | $1,753,000,000 | $1,755,000,000 | $1,218,300,000 |
| Work In Process | $2,413,000,000 | $2,426,000,000 | $2,119,000,000 | $1,599,500,000 |
| Raw Materials | $1,669,000,000 | $1,785,000,000 | $1,592,000,000 | $1,515,200,000 |
| Other Short Term Investments | - | - | - | - |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $2,544,000,000 | $1,506,000,000 | $909,000,000 | $1,381,000,000 |
| Operating Activities | ||||
| Cash Flowsfromusedin Operating Activities Direct | $3,561,000,000 | $2,764,000,000 | $2,601,000,000 | $2,628,700,000 |
| Classesof Cash Receiptsfrom Operating Activities | $4,610,000,000 | $3,980,000,000 | $3,538,000,000 | $3,258,100,000 |
| Other Cash Receiptsfrom Operating Activities | $4,610,000,000 | $3,980,000,000 | $3,538,000,000 | $3,258,100,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,017,000,000 | $-1,258,000,000 | $-1,692,000,000 | $-1,247,700,000 |
| Investing Cash Flow | $-850,000,000 | $-1,259,000,000 | $-11,843,000,000 | $-1,636,100,000 |
| Cash Flow From Continuing Investing Activities | $-850,000,000 | $-1,259,000,000 | $-11,843,000,000 | $-1,636,100,000 |
| Net Other Investing Changes | - | - | - | $-700,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $17,000,000 | $40,000,000 | $34,000,000 | $4,988,400,000 |
| Financing Cash Flow | $-2,241,000,000 | $-1,284,000,000 | $456,000,000 | $7,675,900,000 |
| Cash Flow From Continuing Financing Activities | $-2,241,000,000 | $-1,284,000,000 | $456,000,000 | $7,675,900,000 |
| Net Other Financing Charges | $-89,000,000 | $-99,000,000 | $-160,000,000 | $-102,700,000 |
| Cash Dividends Paid | $-1,434,000,000 | $-1,266,000,000 | $-1,239,000,000 | $-1,038,700,000 |
| Common Stock Dividend Paid | $-1,434,000,000 | $-1,266,000,000 | $-1,239,000,000 | $-1,038,700,000 |
| Net Common Stock Issuance | $17,000,000 | $40,000,000 | $34,000,000 | $4,988,400,000 |
| Common Stock Issuance | $17,000,000 | $40,000,000 | $34,000,000 | $4,988,400,000 |
| Other | ||||
| Repayment Of Debt | $-832,000,000 | $-2,017,000,000 | $-798,000,000 | $-316,400,000 |
| Issuance Of Debt | $97,000,000 | $2,058,000,000 | $2,539,000,000 | $4,092,700,000 |
| Interest Paid Supplemental Data | $412,000,000 | $432,000,000 | $374,000,000 | $172,300,000 |
| Income Tax Paid Supplemental Data | $637,000,000 | $784,000,000 | $563,000,000 | $457,100,000 |
| End Cash Position | $2,157,000,000 | $1,643,000,000 | $1,509,000,000 | $10,334,400,000 |
| Beginning Cash Position | $1,643,000,000 | $1,509,000,000 | $10,334,000,000 | $1,730,100,000 |
| Effect Of Exchange Rate Changes | $44,000,000 | $-87,000,000 | $-39,000,000 | $-64,200,000 |
| Changes In Cash | $470,000,000 | $221,000,000 | $-8,786,000,000 | $8,668,500,000 |
| Net Issuance Payments Of Debt | $-735,000,000 | $41,000,000 | $1,741,000,000 | $3,776,300,000 |
| Net Long Term Debt Issuance | $-735,000,000 | $41,000,000 | $1,741,000,000 | $3,776,300,000 |
| Long Term Debt Payments | $-832,000,000 | $-2,017,000,000 | $-798,000,000 | $-316,400,000 |
| Long Term Debt Issuance | $97,000,000 | $2,058,000,000 | $2,539,000,000 | $4,092,700,000 |
| Net Business Purchase And Sale | $167,000,000 | $-3,000,000 | $-10,534,000,000 | - |
| Sale Of Business | $180,000,000 | - | - | - |
| Purchase Of Business | $-13,000,000 | $-3,000,000 | $-10,534,000,000 | - |
| Net Intangibles Purchase And Sale | $-381,000,000 | $-409,000,000 | $-464,000,000 | $-168,900,000 |
| Purchase Of Intangibles | $-381,000,000 | $-409,000,000 | $-464,000,000 | $-168,900,000 |
| Net PPE Purchase And Sale | $-636,000,000 | $-847,000,000 | $-1,117,000,000 | $-1,078,800,000 |
| Purchase Of PPE | $-636,000,000 | $-849,000,000 | $-1,228,000,000 | $-1,078,800,000 |
| Taxes Refund Paid Direct | $-637,000,000 | $-784,000,000 | $-563,000,000 | $-457,100,000 |
| Interest Paid Direct | $-412,000,000 | $-432,000,000 | $-374,000,000 | $-172,300,000 |
| Sale Of PPE | - | $2,000,000 | $111,000,000 | - |
| Net Investment Purchase And Sale | - | - | $272,000,000 | $-387,700,000 |
| Sale Of Investment | - | - | $272,000,000 | - |
| Purchase Of Investment | - | - | - | $-387,700,000 |
Fetched: 2026-02-02